Chennai Meenakshi Multispeciality Hospital Limited (CMMHOSP.BO)
INR 48.47
(0.0%)
INR 48.47
(0.0%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 15.33 Million | 29.46 Million | 39.66 Million | 33 Million | 29.94 Million | 23.14 Million |
| Net Income | -4.27 Million | 8.98 Million | 39.93 Million | -12.09 Million | 5.69 Million | 424.05 Thousand |
| Depreciation & Amortization | 11.56 Million | 11.79 Million | 11.73 Million | 12.67 Million | 12.43 Million | 11.96 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 6.39 Million | -1.45 Million | -19.19 Million | 22.93 Million | -1.95 Million | -2.71 Million |
| Other non-cash items | 26.42 Million | 10.13 Million | 7.19 Million | 9.49 Million | 13.76 Million | 13.47 Million |
| Investing Cash Flow | -20.63 Million | -9.11 Million | -22.05 Million | -1.4 Million | -9.5 Million | -8.07 Million |
| Investments in PPE | -22.06 Million | -10.85 Million | -24.06 Million | -2.8 Million | -10.8 Million | -8.75 Million |
| Acquisitions | 1.46 Million | 102 Thousand | 42.37 Thousand | 4000.00 | 387.01 Thousand | 102.76 Thousand |
| Investment purchases | -36 Thousand | -9.96 Million | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | 3.5 Million | 1.64 Million | 1.96 Million | 1.39 Million | 915.87 Thousand | 572.31 Thousand |
| Financing Cash Flow | 7.9 Million | -7.45 Million | -16.21 Million | -9.76 Million | -21.22 Million | -14.08 Million |
| Debt repayment | -7.9 Million | - | -8.5 Million | - | -7.35 Million | -461.43 Thousand |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -7.59 Million | - | -7.71 Million | - | -13.86 Million | -13.62 Million |
| Accounts receivables | 5.35 Million | -2.66 Million | -1.36 Million | 12.25 Million | -5.74 Million | -2.85 Million |
| Accounts payables | -7.26 Million | 649 Thousand | 5.14 Million | 9.61 Million | 4.29 Million | -1.58 Million |
| Inventory | 266 Thousand | -310 Thousand | 1.8 Million | 1.06 Million | -509.85 Thousand | 1.72 Million |
| Other working capital | 8.02 Million | 873 Thousand | -24.78 Million | - | - | - |
| Cash at beginning of period | 45.26 Million | 32.36 Million | 30.97 Million | 9.14 Million | 9.92 Million | 8.94 Million |
| Cash at end of period | 37.87 Million | 45.26 Million | 32.36 Million | 30.97 Million | 9.14 Million | 9.92 Million |
| Capital Expenditure | -22.06 Million | -10.85 Million | -24.06 Million | -2.8 Million | -10.8 Million | -8.75 Million |
| Effect of forex changes on cash | - | -1000.00 | - | -2.00 | - | - |
| Net cash flow / Change in cash | -7.39 Million | 12.89 Million | 1.39 Million | 21.83 Million | -781.68 Thousand | 981.8 Thousand |
| Free Cash Flow | -6.72 Million | 18.6 Million | 15.59 Million | 30.19 Million | 19.13 Million | 14.38 Million |
| Breakdown | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -4.27 Million | -404 Thousand | 444 Thousand | 151 Thousand | 2.53 Million | 8.98 Million |
| Depreciation & Amortization | 11.56 Million | 3.01 Million | 3.01 Million | 2.68 Million | 2.89 Million | 11.79 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 6.39 Million | - | - | - | - | -1.45 Million |
| Other non-cash items | 26.42 Million | 3.41 Million | -3.01 Million | -2.68 Million | -2.89 Million | 10.13 Million |
| Investing Cash Flow | -20.63 Million | - | - | - | - | -9.11 Million |
| Investments in PPE | -22.06 Million | - | - | - | - | -10.85 Million |
| Acquisitions | 1.46 Million | - | - | - | - | 102 Thousand |
| Investment purchases | -36 Thousand | - | - | - | - | -9.96 Million |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | 1.64 Million |
| Financing Cash Flow | 7.9 Million | - | - | - | - | -7.45 Million |
| Debt repayment | -7.9 Million | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | 5.35 Million | - | - | - | - | -2.66 Million |
| Accounts payables | -7.26 Million | - | - | - | - | 649 Thousand |
| Inventory | 266 Thousand | - | - | - | - | -310 Thousand |
| Other working capital | 8.02 Million | - | - | - | - | 873 Thousand |
| Cash at beginning of period | 45.26 Million | 43.6 Million | 43.15 Million | 45.26 Million | 42.73 Million | 32.36 Million |
| Cash at end of period | 37.87 Million | 49.62 Million | 43.6 Million | 151 Thousand | 45.26 Million | 45.26 Million |
| Capital Expenditure | -22.06 Million | - | - | - | - | -10.85 Million |
| Effect of forex changes on cash | - | - | - | - | - | -1000.00 |
| Net cash flow / Change in cash | -7.39 Million | 6.02 Million | 444 Thousand | -45.11 Million | 2.53 Million | 12.89 Million |
| Free Cash Flow | -6.72 Million | 6.02 Million | 444 Thousand | 151 Thousand | 2.53 Million | 18.6 Million |
SANDHAR
BALPHARMA
CYBERTECH
RSAU
CANF
SHYAMMETL